Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
‘Stay calm’ and ‘this is the new normal’: What banking CEOs are saying about the global market sell-off
Investors are reeling from President Trump’s new tariffs threat, with markets in the U.S., Europe and Asia facing hefty losses.
Binance says ‘wait and see’ on reentering the U.S. Ripple’s CEO thinks it’s happening
Richard Teng, co-CEO of Binance, called the U.S. “a very important marketplace,” but added it was taking a “wait-and-see” approach.
Watch: Trump to speak at White House press briefing
President Donald Trump is set to appear at a White House press briefing marking the first anniversary of his second term in office.
Stocks making the biggest moves midday: NetApp, Nvidia, Expand Energy, Intel and more
These are the stocks posting the largest moves in midday trading.
Netflix reports earnings after the bell. Here’s what to expect
Netflix this week amended its offer for Warner Bros. Discovery assets amid a Paramount Skydance hostile takeover attempt.
ServiceNow inks deal with OpenAI to boost its AI software stack
ServiceNow has been on an acquisition frenzy as it looks to position itself as a key AI software player.
How pro traders are playing defense against this selloff, according to JPMorgan strategists
JPMorgan strategists said it is prudent to maintain near-term hedges even as their broader outlook on equities remains constructive.
Danish pension fund to sell $100 million in Treasuries, citing ‘poor’ U.S. government finances
AkademikerPension’s move comes amid increasing tensions with the U.S. over Greenland.
Generating income: This natural gas stock has paid a dividend for more than a century
In addition to buying the stock, an investor interested in potentially enhancing income beyond dividends could consider a buy-write options strategy.